300+ investors in your industry, stage, and region Get
Any industry
Artificial Intelligence
Google
EdTech
Clean Energy
Retail
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Organic Food
Email
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Gaming
Facebook
Blockchain
B2B
Social Network
Big Data
Video Games
Education
Wellness
Medical Device
Mobile
Construction
Automotive
Legal
Sports
eSports
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Theatre
Recruiting
Crowdfunding
Web3
Medical
Fashion
Social
Venture Capital
Infrastructure
Beauty
Celebrity
Cannabis
Climate
LGBT
Publishing
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Music
Real Estate
Art
Sporting Goods
Digital Media
Finance
Manufacturing
FinTech
Social Media
Financial Services
Franchise
Non Profit
Mobile Advertising
Internet
Android
Biotech
Proptech
Sustainability
Hardware
Transportation
Impact
Enterprise
Community
Media (Entertainment)
Any country
Burkina Faso
South Korea
Africa
LATAM
Singapore
Brazil
Saudi Arabia
Oceania
Greece
Gibraltar
Norway
Liberia
Mexico
Taiwan
Sweden
Zambia
Puerto Rico
Tunisia
Russian Federation
Togo
Tajikistan
Zimbabwe
Nigeria
Guinea
Nepal
Iran
Kyrgyzstan
Isle of Man
Pakistan
Romania
Oman
Cameroon
Colombia
Australia
New Zealand
China
Sri Lanka
Armenia
Costa Rica
Switzerland
Czech Republic
Kenya
Cayman Islands
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Malawi
Moldova
Botswana
Seychelles
United Kingdom
Japan
South Africa
Egypt
France
Georgia
Denmark
Croatia
Hong Kong
Ghana
Iraq
Mali
Morocco
Myanmar
Latvia
Malaysia
Poland
Philippines
Portugal
Sierra Leone
Rwanda
El Salvador
Senegal
Thailand
Uruguay
Tanzania
India
Germany
Canada
Ireland
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Cyprus
Qatar
United Arab Emirates
Spain
Europe
Angola
Argentina
Bangladesh
Barbados
Belgium
Ethiopia
Jordan
Austria
Azerbaijan
Ecuador
Bulgaria
Bahrain
Bahamas
Faroe Islands
Jersey
Estonia
Bolivia
Algeria
Belize
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Cambodia
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotech VC Funds & Investors in France (July 2026)

The most active venture capital funds investing in France Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in France Biotech startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Bpifrance
VC Fund
82 France, United States, Switzerland Seed, Series A Software, Information Technology, Health Care $726k–$34M
Kurma Partners
VC Fund
28 France, Switzerland, Spain Series A, Seed, Series B Health Care, Biotechnology, Medical $2.3M–$95M
Seventure Partners
VC Fund
27 France, United States, Germany Series A, Series B Biotechnology, Health Care, Software $3.1M–$65M
GO CAPITAL
VC Fund
27 France, Canada, Israel Seed, Series A Biotechnology, Software, Health Care $549k–$13M
Sofinnova Partners
VC Fund
25 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $6.6M–$109M
Karista
VC Fund
23 France, United States, Finland Seed, Series A, Series B Software, Biotechnology, Health Care $713k–$33M
Elaia
VC Fund
20 France, United States, Spain Seed, Series A, Series B Software, Artificial Intelligence, Information Technology $1.1M–$50M
Auriga Partners
VC Fund
17 France, United States, Switzerland Series B, Series A Biotechnology, Health Care, Medical $2.2M–$33M
Angels Santé
VC Fund
16 France, India, United States Seed, Angel Health Care, Biotechnology, Medical Device $658k–$4.6M
Omnes Capital
VC Fund
16 France, Germany, United States Series A, Series B Software, Biotechnology, Health Care $3.5M–$53M
Idinvest Partners
VC Fund
16 France, United States, Spain Series B, Series A Biotechnology, Software, Health Care $3.3M–$66M
Sofimac Investment Managers
VC Fund
12 France, Italy, Austria Seed, Series A Biotechnology, Health Care, Manufacturing $274k–$15M
AQUITI Gestion
VC Fund
11 France, United States Series A, Seed Software, Biotechnology, Manufacturing $170k–$18M
AdBio partners
VC Fund
11 France, Spain, Belgium Seed, Series A Biotechnology, Health Care, Pharmaceutical $2.2M–$37M
Pontifax
VC Fund
10 United States, Israel, France Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $6.3M–$128M
Cap Innov'Est
VC Fund
9 France, United States Seed, Series A Biotechnology, Medical, Health Care $713k–$7.7M
Galia Gestion
VC Fund
8 France, United States Series A, Seed Software, Manufacturing, Biotechnology $531k–$6.9M
Inserm Transfert Initiative
VC Fund
8 France, Switzerland, United States Series A, Series B, Seed Biotechnology, Medical, Health Care $1.1M–$60M
Octalfa
VC Fund
8 France Seed, Series A Biotechnology, Health Care, Medical $658k–$4.6M
Meusinvest (Noshaq)
VC Fund
7 Belgium, France, Germany Series A, Seed Biotechnology, Health Care, Medical $137k–$16M
UI Investissement
VC Fund
7 France, Spain, Canada Private Equity, Seed, Series A Manufacturing, Software, Health Care $1.5M–$49M
Crédit Agricole
VC Fund
7 France, United States, Italy Debt Financing, Seed Energy, Health Care, Software $768k–$1.3B
Sham Innovation Santé
VC Fund
7 France Series B, Series A Biotechnology, Medical Device, Medical $5.7M–$80M
Starquest Capital
VC Fund
7 France, Singapore, United States Seed, Series A Software, Manufacturing, Information Technology $288k–$11M
IRDI SORIDEC Gestion
VC Fund
7 France, Brazil, Singapore Seed, Series A Software, Biotechnology, Medical $1.6M–$13M
BNP Paribas
VC Fund
7 France, United Kingdom, United States Debt Financing, Post-IPO Debt Financial Services, Information Technology, Software $8.5M–$2.5B
WiSEED
VC Fund
7 France, Norway Seed, Equity Crowdfunding Software, Biotechnology, Manufacturing $384k–$3.3M
Demeter
VC Fund
7 France, Germany, Slovenia Seed, Series A Manufacturing, Software, AgTech $1.6M–$27M
IRDI
VC Fund
7 France Series A, Seed Health Care, Software, Biotechnology $757k–$22M
CEA Investissement
VC Fund
6 France, Canada, United States Seed, Series A Manufacturing, Biotechnology, Semiconductor $796k–$21M
Crédit Mutuel Innovation
VC Fund
6 France, United States, Canada Series A, Series B Software, Health Care, Biotechnology $3.3M–$43M
Caisse d’Epargne
VC Fund
6 France Debt Financing, Seed Software, Health Care, Biotechnology $400k–$169M
M Capital Partners
VC Fund
6 France, United States, Canada Seed, Series A Health Care, Software, Food and Beverage $1.1M–$7.7M
XAnge
VC Fund
6 France, Germany, Belgium Series A, Seed, Series B Software, SaaS, E-Commerce $1.1M–$68M
Paca Investissement
VC Fund
6 France Seed, Series A Software, Internet, Manufacturing $329k–$9.2M
SOSV
VC Fund
6 United States, India, United Kingdom Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software
Normandie Participations
VC Fund
5 France Seed, Series A Software, Biotechnology, Health Care $871k–$11M
Eurazeo
VC Fund
5 France, United States, Germany Series B, Seed Software, Information Technology, Health Care $3.2M–$125M
Emertec
VC Fund
5 France, Canada, United States Series A, Series B Energy, Software, Electronics $1.4M–$15M
Entrepreneurs First
VC Fund
5 United Kingdom, United States, India Pre-Seed, Seed, Series A Artificial Intelligence, Software, Information Technology $100k–$60M
Pureos Bioventures
VC Fund
5 France, Switzerland, United States Series A, Series B, Series C Biotechnology, Therapeutics, Medical $6.6M–$125M
Finovam Gestion
VC Fund
5 France, United States Seed, Series A Software, Information Technology, Medical $505k–$12M
Blast. Club
VC Fund
5 France, Germany Seed, Series A Biotechnology, Information Technology, Apps $2.7M–$32M
Kima Ventures
VC Fund
5 France, United States, United Kingdom Seed, Pre-Seed, Series A Software, Artificial Intelligence, SaaS $550k–$16M
Galion.exe
VC Fund
5 France, The Netherlands, Germany Seed, Pre-Seed, Series A Software, Artificial Intelligence, Biotechnology $1.1M–$23M
IXO Private Equity
VC Fund
5 France, United States, Canada Private Equity, Series A Health Care, Manufacturing, Biotechnology
Andera Partners
VC Fund
5 France, United States, Germany Series B, Private Equity Biotechnology, Health Care, Medical $14M–$247M
M Ventures
VC Fund
4 United States, United Kingdom, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics
HealthCap
VC Fund
4 United States, Sweden, France Series B, Series A Biotechnology, Health Care, Medical $5.7M–$92M
BNP Paribas Développement
VC Fund
4 France, Germany, The Netherlands Series A, Seed Software, Health Care, Information Technology $2M–$25M
Access all 999 VC funds in France Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Bpifrance
VC Fund · Maisons-alfort, Ile-de-France, France · 82 investments in France Biotech startups

Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A
  • Geography: France, United States, Switzerland

Investor stats

  • Total investments: 1273
  • Round size: Seed $726k–$6.5M; Series A $2.7M–$34M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • AQEMIA — Aqemia is an in silico drug discovery start-up, whose ambition is to discover rapidly more innovative therapeutic molecules with better chances of success.
  • EG 427 — EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.
  • AI-Stroke — Developer of an artificial intelligence-powered mobile application designed to assist in pre-CT/MRI stroke diagnostics. The company offers a platform that guides first responders and patients through relevant exercises for stroke detection, captures and analyzes video data, and leverages the world's largest proprietary stroke patientvideo dataset (20,000 videos and 6 million images), enabling patients with a diagnosis and outcomes by reducing delays in treatment for stroke, increasing the number of treatment procedures, and recuding the rehab costs.
Show all investments...

Kurma Partners
VC Fund · Paris, Ile-de-France, France · 28 investments in France Biotech startups

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Seed, Series B
  • Geography: France, Switzerland, Spain

Investor stats

  • Total investments: 138
  • Round size: Seed $2.3M–$17M; Series A $3.8M–$95M; Series B $12M–$72M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • EvlaBio — EvlaBio is a biotech company focused on the development of drug programs that address significant unmet medical needs. The company's pipeline includes robust scientific antibody programs for the treatment of hepatocellular carcinoma (Phase 1 ready) and chronic kidney disease with left ventricular hypertrophy (pre-clinical).
  • AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
  • DAMAE Medical — Damae Medical is a Paris, France-based medtech company. It has developed a medical device capable of seeing biological tissues in depth, at a cellular level and in vivo. This innovative optical imaging technology will especially allow dermatologists to evaluate in a precise, efficient and rapid way malignancy of tumors by a simple contact with thesurface of the skin. DAMAE Medical’s mission is to put the great power of bio-photonics at the service of opening new opportunities in medical imaging and diagnosis.
Show all investments...

Seventure Partners
VC Fund · Paris, Ile-de-France, France · 27 investments in France Biotech startups

Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion undermanagement as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series A, Series B
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 239
  • Round size: Series A $3.1M–$27M; Series B $3.4M–$65M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • ErVimmune — Our team is focused on bringing breakthrough immunotherapies in unmet medical needs for cancer patients. Check our work!
  • Kainova Therapeutics — Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression
  • BAOUW / Outdoor Organic Nutrition — A raw, healthy, and natural diet made up of energy gels, energy bars, and energy fruit purees.
Show all investments...

GO CAPITAL
VC Fund · Rennes, Bretagne, France · 27 investments in France Biotech startups

GO Capital is an independent management company and a major player in regional Seed and Venture Capital since 2003. With offices in Brittany, Pays de la Loire, Normandy, Centre-Val de Loire and the South of France, GO Capital contributes to the financing of responsible innovation in these regions. With a team of investors with complementarysectoral experience, we have a solid track-record in DeepTech. GO Capital has nearly 400 million euros under management, and mainly finances technology leaders in the digital and healthcare sectors and in the industry of the future.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Seed, Series A
  • Geography: France, Canada, Israel

Investor stats

  • Total investments: 137
  • Round size: Seed $549k–$6.6M; Series A $2.1M–$13M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • AISPRID — AISPRID is a robotic company that manufactures autonomous robots for soft fruit picking.
  • Axomove — Axomove is an e-health app that specializes in video physical exercises.
  • NeoXperiences — NeoXperiences develops technological solutions that bring audiences together around fun and interactive experiences.
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 25 investments in France Biotech startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 319
  • Round size: Series A $6.6M–$70M; Series B $10M–$109M; Series C $12M–$100M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: Likely still investing — raised $200M in 2023

Portfolio highlights

  • Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
  • GFBiochemicals — GFBiochemicals is the only company to produce levulinic acid at commercial scale directly from biomass.In 2008, a group of biobased chemical experts saw the significant potential of levulinic acid to replace petroleum-based products across a range of market sectors. GFBiochemicals was founded to develop the production technology needed for thisrevolution in chemicals and biofuels.GFBiochemicals demonstrated these breakthrough technologies in the Caserta plant, in partnership with the University of Pisa and the Polytechnic University of Milan. This commercial-scale plant was retrofitted with new conversion, recovery and purification technology.
  • Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
Show all investments...

Karista
VC Fund · Paris, Ile-de-France, France · 23 investments in France Biotech startups

Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: France, United States, Finland

Investor stats

  • Total investments: 150
  • Round size: Seed $713k–$6.5M; Series A $1.2M–$23M; Series B $2.5M–$33M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • CYSEC — Secure your sensitive data in the cloud and in the edge with ARCA Trusted OS and open the door to innovation with confidential computing.
  • Tricares — TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.
  • Acticor Biotech — Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke. Acticor Biotech’s project stems from the sheer need for new therapeutic options to manage stroke. According to the World Health Organization, 15 million people suffer stroke worldwide each year. Of these, 5 milliondies and another 5 million are permanently disabled. Stroke is the third cause of death in the world and the leading cause of death among women. It is also the first cause of adult acquired disabilities resulting from the neurological damages sustained by 75% of the survivors. However, only one treatment is presently recommended by health authorities and is it estimated that only 15% of ischemic stroke patients are treated with it, with less than 40% efficacy. So while this treatment is very useful for ischemic stroke, a major need for a new treatment capable of effectively treating a majority of ischemic stroke patients remains.Acticor Biotech was founded in November 2013 and is headquartered in Paris, France.
Show all investments...

Elaia
VC Fund · Paris, Ile-de-France, France · 20 investments in France Biotech startups

Elaia is French venture capital firm focused on European digital and deep tech startups, from early stage to growth developpement. We back tech disruptors.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: France, United States, Spain

Investor stats

  • Total investments: 218
  • Round size: Seed $1.1M–$9.9M; Series A $2.2M–$26M; Series B $4.2M–$50M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: Likely still investing — fund raised in 2024

Portfolio highlights

  • Hema.to — Hema.to provides fully automated, AI-powered blood cancer detection suggestions based on flow cytometry data.
  • Nano Corp — Deep network analysis for everyone
  • Vibe — Advertise your brand on CTV & OTT content with Vibe's self-serve ad platform to target hundreds of channels & networks and reach millions of households.
Show all investments...

Auriga Partners
VC Fund · Paris, Ile-de-France, France · 17 investments in France Biotech startups

Since 1998, AURIGA PARTNERS, an independent Venture Capital firm, has been managing several early stage funds specializing in Information Technology and Life Sciences.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A
  • Geography: France, United States, Switzerland

Investor stats

  • Total investments: 128
  • Round size: Series A $2.2M–$14M; Series B $3.8M–$33M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • Availpro — D-EDGE empowers 17,000+ hotels to boost revenue with CRS, Booking Engine, Channel Manager, hospitality-focused websites & digital marketing solutions.
  • Nexthink — Discover what your employees need, see what they experience, know how they feel. Deliver IT that delights.
  • Bonitasoft — Bonita helps businesses automate workflows, boost efficiency, and turn complexity into a competitive edge. Unlock the power of process automation today!
Show all investments...

Angels Santé
VC Fund · Puteaux, Ile-de-France, France · 16 investments in France Biotech startups

Angels Santé is the leading French Business Angel Network solely dedicated to Healthcare investments.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Seed, Angel
  • Geography: France, India, United States

Investor stats

  • Total investments: 37
  • Round size: Seed $1.1M–$4.6M; Angel $658k–$1.3M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Kimialys — Kimialys provides a patented and disruptive surface chemistry for biosensors, enabling the development of innovative rapid diagnostic assays.
  • StemInov — StemInov is a biotechnology company that focuses on the development of stem cell therapies for inflammatory diseases. The company's primary focus is on critical care, specifically septic shock and Acute Respiratory Distress Syndrome (ARDS). StemInov's approach is based on robust preclinical data and widely accepted safety measures. Thecompany is developing an off-the-shelf and allogenic cell therapy. StemInov is also working on a drug-based therapy using mesenchymatous stem cells from Wharton's jelly (WJ-MSC).
  • SeaBeLife — SeaBeLife is a biotechnology company that develops a range of drug candidates intended to block regulated necrosis (or regulated cell death of cells), from a family of patented molecules.
Show all investments...

Omnes Capital
VC Fund · Paris, Ile-de-France, France · 16 investments in France Biotech startups

Omnes VC is the Venture Capital arm of Omnes Capital, a leading private equity firm dedicated to energy transition and innovation with €4.8 billion in assets under management and a 20 year + experience in: venture capital, buyout & growth capital, private debt, renewable energy, co-investment, secondary funds of funds. Omnes Capital is fullyindependent.With 65 business sales including 14 IPOs carried out in 16 years, Omnes VC is one of the key players in France in financing innovative SMEs with expertise in both Technology and Healthcare sectors. Omnes VC has supported 120 companies and has invested more than €500M in businesses such as Scality, Novaled, BioVex, arGEN-X, Pixium, Blablacar.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Series A, Series B
  • Geography: France, Germany, United States

Investor stats

  • Total investments: 181
  • Round size: Series A $3.5M–$44M; Series B $4.4M–$53M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — raised $403M in 2020

Portfolio highlights

  • VSORA — VSORA provides high performance companion solutions combining AI and signal processing to enable autonomous driving and ADAS
  • SeqOne Genomics — Healthcare is undergoing a revolution, known as genomic medicine, that uses the patient’s genomic information to optimise treatment. This trend is accelerating thanks to the arrival of New Generation Sequencing (NGS) techniques that have reduced the cost of decoding genomic material while increasing the amount useful data obtained. However, NGShas had only limited impact on mainstream healthcare due to the difficulties in analyzing more and richer genomic data. SeqOne’s mission is to provide tools that enable the healthcare industry to analyse NGS genomic data better and more cost-effectively to provide universal access to genomic medicine.
  • Complix — Complix is a biopharmaceutical company focused on the discovery and development of Alphabodiesâ„¢, a novel class of biopharmaceuticals that offer significant advantages over existing protein based therapies. Alphabodiesâ„¢ bind with high affinity to a wide range of disease targets and are particularly suited to address certain targets that aredifficult to reach with antibodies or other types of protein scaffolds. Due to their unique stability and versatility Alphabodiesâ„¢ can be delivered via alternative non-injectable routes of administration, unlike most therapeutic proteins.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Idinvest Partners
VC Fund · Paris, Ile-de-France, France · 16 investments in France Biotech startups

Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Series B, Series A
  • Geography: France, United States, Spain

Investor stats

  • Total investments: 252
  • Round size: Series A $3.3M–$24M; Series B $7.8M–$66M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — raised $88M in 2021

Portfolio highlights

  • LumApps — LumApps is the only intranet packaged solution that enables employees to feel connected to their organization and engaged in their work from anywhere by delivering a modern, smart digital headquarters that empowers your employees to design a work experience that works for them.
  • Ornikar — Ornikar is an online driving school that offers radically cheaper, uncomplicated and faster offer to obtain a driving license.Ornikar relies on a network of state-qualified teachers to offer an apprenticeship in mobile driving at reduced prices. The cmpany is an an online driving school more in tune with the demand of current and futuregenerations.The company's mission is to make the driver's license exam cheaper and its learning more enjoyable.
  • Pretty Simple — Video games studio based in Paris, France. Makers of Criminal Case and Sorcery School.
Show all investments...

Sofimac Investment Managers
VC Fund · Clermont-ferrand, Auvergne, France · 12 investments in France Biotech startups

Acteur incontournable du capital risque de proximité, SOFIMAC PARTNERS accompagne depuis maintenant plus de 30 ans les PME régionales dans le financement de leur développement à moyen / long terme. Répondant à la problématique de sous capitalisation des PME françaises, SOFIMAC PARTNERS intervient en fonds propres aux côtés des chefsd’entreprises quelle que soit leur problématique : Création, Développement, Transmission. Gérant 200 M€ d’actifs au travers de 16 fonds (FCPR, FCPI, SCR, FIP,…), notre groupe réalise ses investissements sur une grande variété de secteurs, couvrant aussi bien les activités traditionnelles que technologiques (chimie verte, éolien, chaudronnerie aéronautique, e-commerce, édition de logiciel, médecine nucléaire etc…)

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Manufacturing
  • Stage:Seed, Series A
  • Geography: France, Italy, Austria

Investor stats

  • Total investments: 73
  • Round size: Seed $274k–$2.2M; Series A $1.6M–$15M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Ultrawatt — Ultrawatt is a mission-driven startup to improve urban architecture while making a beneficial social and environmental effect.
  • Mob-Energy — Mob-Energy is a privately held company specializing in the development of mobile and innovative charging solutions. It designs autonomous charging robots capable of moving energy where it is needed, optimizing the site's existing infrastructure. The company was founded in 2018 and is headquartered in Villeurbanne, Auvergne-Rhône-Alpes.
  • Snowleader — Votre boutique en ligne (qui sent bon le reblochon) spécialiste des sports d’hiver, outdoor et street.
Show all investments...

AQUITI Gestion
VC Fund · Bordeaux, Aquitaine, France · 11 investments in France Biotech startups

Floated in 1998, thanks to the local authority "Conseil Régional d’Aquitaine" and the "Caisse des dépôts", our venture, growth and LBO funds (Aquitaine Amorçage, ACI, Aqui-Invest) now benefit from the support of public and private influential shareholders and sponsors.Up to now, AQUITI GESTION has invested in more than 200operations contributing to the creation and development of about 150 companies and thousands of jobs.Currently, ACI and Aqui-Invest manage a portfolio gathering 50 companies which revenues scale from 0 € (early stage) to 30 M€.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Manufacturing
  • Stage:Series A, Seed
  • Geography: France, United States

Investor stats

  • Total investments: 58
  • Round size: Seed $170k–$4.1M; Series A $849k–$18M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — raised $6.4M in 2010

Portfolio highlights

  • Synboli
  • Aquassay — Aquassay assists you with improving the industrial and environmental performance of all your water usage (supply, production, discharge).
  • CardNexus — CardNexus provides a digital platform for managing, trading, and selling trading card collections.
Show all investments...

AdBio partners
VC Fund · Paris, Ile-de-France, France · 11 investments in France Biotech startups

AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Seed, Series A
  • Geography: France, Spain, Belgium

Investor stats

  • Total investments: 32
  • Round size: Seed $2.2M–$18M; Series A $18M–$37M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $116M in 2021

Portfolio highlights

  • Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
  • ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
  • Integra Therapeutics — Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
Show all investments...

Pontifax
VC Fund · Herzliya, Tel Aviv, Israel · 10 investments in France Biotech startups

Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Israel, France

Investor stats

  • Total investments: 113
  • Round size: Series A $6.3M–$110M; Series B $20M–$128M; Series C $12M–$101M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $14M in 2020

Portfolio highlights

  • ArQule — ArQule, Inc. is a clinical-stage biotechnology company engaged in the research and development of cancer therapeutics. The Company employs technologies, such as its ArQule Kinase Inhibitor Platform (AKIP) to design and develop drugs. The Company's product is ARQ 197, an orally administered inhibitor of the c-Met receptor tyrosine kinase. ARQ197 is being evaluated as monotherapy and in combination therapy in a Phase II clinical development program that includes trials in Microphthalmia Transcription Factor (MiT) associated tumors, non-small cell lung cancer (NSCLC), pancreatic adenocarcinoma and hepatocellular carcinoma (HCC). The Company has licensed commercial rights to ARQ 197 for human cancer indications to Daiichi Sankyo Co., Ltd. (Daiichi Sankyo) in the United States, Europe, South America and the rest of the world, excluding Japan and certain other Asian countries, where it has licensed commercial rights to Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin).
  • Graviton Bioscience — Curing Disease through Restored Homeostasis
  • Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
Show all investments...

Cap Innov'Est
VC Fund · Illkirch-graffenstaden, Alsace, France · 9 investments in France Biotech startups

Cap Innov’Est is a 36M€ tri-regional fund dedicated to investments in young innovative start-ups. Cap Innov’Est was launched in July 2014 and has already invested in 13 start-ups. Cap Innov’Est is supported by Fonds National d’Amorçage, the 3 Regions Alsace, Bourgogne and Franche-Comté, SAFIDI, caisses d’épargne d’Alsace etBourgogne/Franche-Comté, BNP Paribas et CIFC

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Seed, Series A
  • Geography: France, United States

Investor stats

  • Total investments: 18
  • Round size: Seed $713k–$2.7M; Series A $7.5M–$7.7M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: May invest from a new fund soon — raised $42M in 2014

Portfolio highlights

  • PeptiMimesis — PeptiMimesis is a strategic partner in the design, the discovery and the early development of transmembrane therapeutic peptides. Our innovative approach enables the identification of peptidomimetic candidates interfering with the hetero- and/or the homodimerization of target receptors.PeptiMimesis will develop its pipeline against keytargets in the fields of oncology, immuno-oncology and immune disease and is open to initiate collaboration with pharma partners on receptors of interest.
  • Inoviem Scientific — Our groundbreaking label-free technologies enable you to detect and identify the clinical power of, and weaknesses in, your compound from early-stage pre-clinical R&D through to clinical trials
  • Rhythm Diagnostic Systems — Many of our team have worked together on different projects and in different companies over the last 30-plus years. We are experienced technology, medical, health care and biotech professionals, with long, successful histories in Silicon Valley and elsewhere.
Show all investments...

Galia Gestion
VC Fund · Bordeaux, Aquitaine, France · 8 investments in France Biotech startups

Galia Gestion is a private equity and venture capital firm. GALIA Gestion is a “management company” approved by the AMF, with majority shareholder Alliance Entreprendre.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Biotechnology
  • Stage:Series A, Seed
  • Geography: France, United States

Investor stats

  • Total investments: 55
  • Round size: Seed $531k–$2.9M; Series A $849k–$6.9M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — raised $21M in 2013

Portfolio highlights

  • Wizaly — Wizaly's ambition is to help advertisers understand the impact of their online & offline marketing channels across all conversions, helping clients improve the ROI of their marketing budgets by up to 30%.The Wizaly platform applies its algorithmic attribution technology to provide a holistic and unbiased vision of campaigns performancestogether with actionable optimization recommendations.
  • Agenium — Agenium offers career perspectives in an international and tech environment. They offer this through the specific expertise of their business units. They offer solutions to the business and of the defense, industry, and space sectors.
  • Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.
Show all investments...

Inserm Transfert Initiative
VC Fund · Paris, Ile-de-France, France · 8 investments in France Biotech startups

Inserm Transfert Initiative is a seed stage life science vehicle currently managing about €4.2M for the financing of new biotech companies. Inserm Transfert Initiative is the new investment vehicle of INSERM in France.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: France, Switzerland, United States

Investor stats

  • Total investments: 22
  • Round size: Seed $2.7M–$3.6M; Series A $1.1M–$35M; Series B $2.2M–$60M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Eyevensys — Eyevensys is a address critical unmet needs in ophthalmology by providing a much better way of delivering ophthalmic drugs that overcomes the limitations of current options, such as intravitreal injections, surgery, intravitreal implants and biodegradable formulations. All of these current options have their drawbacks, given they are invasiveprocedures. Eyevensys’ goal is not only to improve short and long term therapeutic outcomes, but also to enhance compliance, improve ocular bioavailability and tolerability.They plan to build a high value product pipeline by enabling sustained production of therapeutic proteins in the eye that will deliver improved clinical outcomes while reducing the burden of frequent intravitreal or systemic injections and other invasive procedures.
  • VectivBio — Explore Ironwood Pharmaceuticals' commitment to GI health with innovative therapies, patient-focused research, and a vision to improve digestive disease treatment.
  • Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
Show all investments...

Octalfa
VC Fund · Écully, Rhone-Alpes, France · 8 investments in France Biotech startups

Octalfa is a France-based venture capital firm that offers a range of financial services.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: France

Investor stats

  • Total investments: 20
  • Round size: Seed $658k–$4.6M; Series A $1.5M–$3.7M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Kimialys — Kimialys provides a patented and disruptive surface chemistry for biosensors, enabling the development of innovative rapid diagnostic assays.
  • Sirius NeoSight — Sirius NeoSight is a biotech and pharmaceutical company that detects subclinical neo-cancers and provide treatment for it.
  • Ventuno Biotech — Ventuno Biotech is a biotech company that is developing innovative cancer therapies.
Show all investments...

Meusinvest (Noshaq)
VC Fund · Liège, Liege, Belgium · 7 investments in France Biotech startups

Noshaq offers financial services to help businesses develop.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Seed
  • Geography: Belgium, France, Germany

Investor stats

  • Total investments: 77
  • Round size: Seed $137k–$6M; Series A $3.3M–$16M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • TrustUp — TrustUp is the home contractors platform, connects homeowners with verified quality home improvement.
  • Le Fourgon — Le Fourgon provides contained drinks for home delivery. They offer milk, water, beer, wine, fruit juice, and sodas. They allow customers to have their drinks delivered free of charge during the day.
  • Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
UI Investissement
VC Fund · Paris, Ile-de-France, France · 7 investments in France Biotech startups

Since 1967, the UI brand embodies a partnership with companies. Actor of the economy, UI has accompanied more than 120 SMEs over the last fifteen years, investing more than 550m € and giving substance to their development projects. Combining experience and corporate culture, UI has established itself as an involved and independent partner, able tocount on its shareholder leaders to favor, independently, the sustainable performance of the SMEs it accompanies.

Show more...

Investment focus

  • Industry: Manufacturing, Software, Health Care
  • Stage:Private Equity, Seed, Series A
  • Geography: France, Spain, Canada

Investor stats

  • Total investments: 105
  • Round size: Seed $1.5M–$6.6M; Series A $3.3M–$33M; Private Equity $3.1M–$49M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — raised $37M in 2021

Portfolio highlights

  • Eclore — Eclore utilizes origami-inspired designs to produce cylindrical and flat protective bellows, as well as specific protection kits for SCARA robots. These components are constructed from materials resistant to solvents, oils, ultraviolet rays, and high-pressure cleaning while maintaining compliance with international standards. The products functionthrough compression and expansion cycles to safeguard equipment from environmental contaminants and mechanical wear. By reducing the total number of parts and overall bulk, the folding technology creates lightweight protective barriers suitable for various industrial diameters.
  • Bobine Chemistry
  • B Capital Partners — B Capital Partners is a financial services firm offering investment advisory solutions with a focus on infrastructure and clean energy.
Show all investments...

Crédit Agricole
VC Fund · Paris, Ile-de-France, France · 7 investments in France Biotech startups

Credit Agricole is a banking corporation with focuses on corporate and investment banking, retail banking, and savings management. Crédit Agricole Group is a responsible, helpful bank serving 49 million customers, 7.4 million mutual shareholders, and 1.2 million shareholders. Crédit Agricole Group supports its customers in their plans and projectsin France and around the world, through its operations in all segments of the market including insurance, real estate, payment systems, asset management, leasing and factoring, consumer finance, and corporate and investment banking. Crédit Agricole also stands out for its dynamic, innovative corporate social responsibility policy serving the economy. This policy is based on a pragmatic approach that permeates throughout the entire Group and engages all its employees. Its recent inclusion in the Vigeo-NYSE Euronext extra-financial indices is recognition of this engagement.

Show more...

Investment focus

  • Industry: Energy, Health Care, Software
  • Stage:Debt Financing, Seed
  • Geography: France, United States, Italy

Investor stats

  • Total investments: 172
  • Round size: Seed $768k–$6M; Debt Financing $2.1M–$1.3B
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • Crelan — Crelan is a co-operative bank that offers a wide range of banking and insurance products to individuals and entrepreneurs.
  • BCC — BCC is a provider of banking and financial services.
  • Calicéo — Calicéo operates as a family group of aquatic fitness and beauty-massage spaces.
Show all investments...

Sham Innovation Santé
VC Fund · Lyon, Rhone-Alpes, France · 7 investments in France Biotech startups

Sham Innovation Sante is an innovation capital vehicle controlled and held by Sham, a mutual insurer specialized in risk management for health care, social welfare and community health organizations. Advised by Turenne Capital, Sham Innovation Sante's mission is to support innovative businesses in the health care sector through the growth anddevelopment phases of their life cycle.

Show more...

Investment focus

  • Industry: Biotechnology, Medical Device, Medical
  • Stage:Series B, Series A
  • Geography: France

Investor stats

  • Total investments: 16
  • Round size: Series A $5.7M–$74M; Series B $9.9M–$80M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Cairdac — Cairdac is a manufacturer of autonomous leadless pacing transcatheter system capable of powering the device with no battery-life limitation.
  • Therapixel — Therapixel is one of the leading French software companies specializing in artificial intelligence applied to medical imaging.
  • Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.
Show all investments...

Starquest Capital
VC Fund · Paris, Ile-de-France, France · 7 investments in France Biotech startups

High Tech, Low Carbon: crafting tomorrow, today. We finance innovation to make tomorrow happen today. Starquest is a Montefiore Company.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Information Technology
  • Stage:Seed, Series A
  • Geography: France, Singapore, United States

Investor stats

  • Total investments: 115
  • Round size: Seed $288k–$7.7M; Series A $1.1M–$11M
  • Lead/follow: 20% lead, 80% follow
  • Last fund: Likely still investing — raised $59M in 2021

Portfolio highlights

  • Ubees — UBEES is the first to offer actionable beekeeping initiatives to global consumer brands to accelerate their 2030 sustainable commitments. Thanks to its proprietary technology, UBEES convert any farmer to become a beekeeper in 90 days, boosting significantly any farmer's livelihood.
  • Heliup — Heliup is a company that creates and manufactures solar systems for huge building roofs for commercial and industrial buildings.
  • Cailabs — Cailabs is a French deep tech company, based in Rennes, which designs, produces and sells photonic solutions to fully exploit the industrial potential opened up by the shaping of light.Cailabs develops and produces a unique range of optical components based on its know-how and its patented technological innovations, in particular Multi-PlaneLight Conversion (MPLC).
Show all investments...

IRDI SORIDEC Gestion
VC Fund · Toulouse, Midi-Pyrenees, France · 7 investments in France Biotech startups, 7 in the past 12 months

IRDI SORIDEC Gestion is a portfolio management company that supports startups, SMEs, and ETIs in the greater South-West of France with equity capital at all stages of development.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: France, Brazil, Singapore

Investor stats

  • Total investments: 53
  • Round size: Seed $1.6M–$5.8M; Series A $3.7M–$13M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Donecle — Automated aircraft inspections by drone for airlines and MRO. Donecle makes aircraft maintenance faster, safer and more reliable. Our unique technology combines 100% automated drone and image analysis algorithms to detect defects, lightning strikes, evaluate paint wear and check placards.
  • Nepting — NEPTING is a company specializing in payment solutions and services with the main objective of supporting business in its evolution. Listening to its customers, it brings a skill, a culture, an innovative offer for all existing, emerging and future payment methods.NEPTING equips all types of points of acceptance with its multi-channel andmulti-vendor electronic payment system and its secure solutions in compliance with the standards in force. It is distinguished by its ability to give its customers the many advantages of a single and homogeneous offer for all its sales channels: mPOS, Retail, TPE, Automate, e-commerce ...
  • DiappyMed — DiappyMed specializes in developing platforms to calculate insulin dosages.
Show all investments...

BNP Paribas
VC Fund · Paris, Ile-de-France, France · 7 investments in France Biotech startups

BNP Paribas provides banking, financing, investment, savings, and protection solutions. The Group's three operational divisions are mobilized to support each type of clientele in their growth and development projects including corporate and institutional banking, commercial, personal banking, investment and protection services. The companyprovide financing and investment services to retail customers, associations, businesses, and corporations.

Show more...

Investment focus

  • Industry: Financial Services, Information Technology, Software
  • Stage:Debt Financing, Post-IPO Debt
  • Geography: France, United Kingdom, United States

Investor stats

  • Total investments: 290
  • Round size: Post-IPO Debt $40M–$2.5B; Debt Financing $8.5M–$1.6B
  • Lead/follow: 19% lead, 81% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Worldline — Worldline is the platform that provides payments and transactional services.
  • Nature Metrics — NatureMetrics is a world-leading provider of biodiversity monitoring data, using environmental DNA (eDNA) surveys, metabarcoding and more.
  • Encompass — Award-winning EC360 CDI platform and EC solutions for fast, flawless, and frictionless corporate client identity validation and verification.
Show all investments...

WiSEED
VC Fund · Toulouse, Midi-Pyrenees, France · 7 investments in France Biotech startups

Wiseed is a crowdfunding platform that enables its users to invest in SMEs and enterprises. The platform offers investments for startups, real-estate firms, social innovation and renewable energy projects, and agriculture firms. It was founded in 2008 by Nicolas Seres and Thomas Merquiol and is based in Toulouse.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Manufacturing
  • Stage:Seed, Equity Crowdfunding
  • Geography: France, Norway

Investor stats

  • Total investments: 31
  • Round size: Seed $384k–$3.3M; Equity Crowdfunding $466k–$2.7M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Aéronde — The Aéronde is an innovative electric airship with a toroidal shape (giant donut) of 15 meters in diameter, designed to offer a silent, energy-efficient flight with very low environmental impact. Inflated with approximately 400 m³ of helium, it can carry up to two people and equipment, with a payload of 200 kg .
  • Vaxinano — Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human and veterinary vaccines and drug delivery systems. Vaxinano was created in 2016, building on 25 years of research and clinical trials on vaccines and the patented technology of Pr Didier Betbeder.
  • BiPER Therapeutics — BiPER Therapeutics is a biotech company to develop and commercializes novel therapeutics.
Show all investments...

Demeter
VC Fund · Paris, Ile-de-France, France · 7 investments in France Biotech startups

Demeter is a major player in venture capital and private equity for the energy and ecological transition. They invest from 500 K€ to 30 M€ to support companies at all stages of their development: innovative startups, high growth SMEs and infrastructure projects.

Show more...

Investment focus

  • Industry: Manufacturing, Software, AgTech
  • Stage:Seed, Series A
  • Geography: France, Germany, Slovenia

Investor stats

  • Total investments: 96
  • Round size: Seed $1.6M–$5M; Series A $4.4M–$27M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • Lixo — Lixo develops software solutions to improve the performance of recycling companies, from waste collection to sorting and recyling
  • AISPRID — AISPRID is a robotic company that manufactures autonomous robots for soft fruit picking.
  • SWEETCH Energy — SWEETCH Energy is developing a breakthrough technology in the field of salinity gradient power harvesting.
Show all investments...

IRDI
VC Fund · Toulouse, Midi-Pyrenees, France · 7 investments in France Biotech startups

IRDI Gestion aims to participate in the economic growth and job creation in their regions. For this, their teams create a real partnership with the companies they accompany, based on a relationship of trust and proximity.IRDI Gestion currently manages €150 million and has financial tools able to accompany the Southwest SMEs in the creationphase, development or transmission, with intervention tickets from equity € 100000 to € 5000000.Precursor of regional investment capital of the Southwest, with a presence of over 35 years, the IRDI Group consists of 3 SCR:- IRDI, created in 1981 to foster industrial growth companies based in the South West of France- MPcroissance, created in 1996 to assist small businesses in Midi-Pyrénées- IRDInov, created in 2012 under the leadership of the National Seed Fund (under the PIA) to fund the initiation of innovative companiesIn 2015, the management company IRDI Gestion, approved by the AMF, was formed to structure the group and bring new development projects.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Series A, Seed
  • Geography: France

Investor stats

  • Total investments: 45
  • Round size: Seed $757k–$9.2M; Series A $1.6M–$22M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • FineHeart — Our mission is to address the unmet need of patients with sever heart failure
  • REEV — REEV motorizes medical orthoses to help millions of people affected by gait disorders to walk, stand, sit and climb stairs with greater ease every day.
  • Starfish Bioscience — STARFISH Bioscience focuses on the creation and development of microbiological solutions for agriculture and vineyards. Our objective is to regenerate soils by restoring their microbiomes, increasing sustainability and productivity while minimizing environmental impact. We are dedicated to improving humanity's well-being and preserving theearth by inventing technologies that address the future difficulties of global agriculture.
Show all investments...

CEA Investissement
VC Fund · Paris, Ile-de-France, France · 6 investments in France Biotech startups

CEA Investissement (SA), founded (as CEA Valorisation) in 1999, is a subsidiary of the CEA, a major player in technological research, development and innovation. The central mission of CEA Valorisation is to create economic value based on technological innovations. To fulfill this mission, they have developed two main activities: Investmentin seed capital in innovative start-ups / start-ups active in the technology areas of CEA. The Licensing of advising companies and public laboratories of innovation in creative strategy development and marketing rights to patent or know-how belonging to the CEA, other research organizations or innovative companies. In addition, CEA contributes to the financing of national investment in seed technology (activity "Fund of Funds"), this activity is developed through particular Emertec management and funds managed by this company (FCPR Emertec 2 Emertec Energy and Environment), the FCPR managed by ACE Security Management SA, an investment company in seed priming Minatec SAS. Their areas of technological expertise are mainly micro-and nanotechnology, health technologies, the New Technologies for Information and Communication (NTIC), advanced materials and technologies for energy.

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Semiconductor
  • Stage:Seed, Series A
  • Geography: France, Canada, United States

Investor stats

  • Total investments: 45
  • Round size: Seed $796k–$21M; Series A $1.4M–$13M
  • Lead/follow: 4% lead, 96% follow
  • Last fund: May invest from a new fund soon — last raise in 2013

Portfolio highlights

  • iNGage — iNGage is a manufacturer of high-performance inertial MEMS navigation sensors for high-volume autonomous mobility markets
  • STELLARIA — Stellaria is a 200 MWe molten salt reactor with 20-year autonomy, delivering safe, sustainable nuclear power without refueling.
  • STELLARIA — Stellaria is reimagining sustainable rapid neutron nuclear energy.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Crédit Mutuel Innovation
VC Fund · Paris, Ile-de-France, France · 6 investments in France Biotech startups

Crédit Mutuel Innovation is the evergreen venture capital entity of Crédit Mutuel Equity (€3.5 billion in capital). We invest €1-20M in life science, digital and deeptech companies from seed to growth stages.We help bold and ambitious entrepreneurs to develop their strong growth potential with our worldwide enterprise ecosystem (our 350+portfolio companies, our abroad subsidiaries, 150+ largest global corporates and the best-in-class experts). Because it takes more than 5 years to build a Unicorn, we invest our own equity and ensure durable partnerships with visionary leaders.Today, the 350 companies in which we have invested generate a cumulative annual turnover of €50bn and create more than 250,000 jobs.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A, Series B
  • Geography: France, United States, Canada

Investor stats

  • Total investments: 97
  • Round size: Series A $3.3M–$26M; Series B $6.7M–$43M
  • Lead/follow: 34% lead, 66% follow

Portfolio highlights

  • STIMIO — Anticipation de pannes, priorisation d'actions de maintenance, optimisation de l'exploitation avec les solutions IoT de Stimio.
  • Invenis — Invenis Helps Data Driven Businesses Taking Better Business Decisions Powered by Big Data and Artificial Intelligence
  • Standing Ovation — Animal-free dairy cheese
Show all investments...

Caisse d’Epargne
VC Fund · Paris, Ile-de-France, France · 6 investments in France Biotech startups

Caisse d’Epargne is a cooperative bank that supports all economic players. It shares its values ​​of social responsibility and humanism with its member customers. It is committed to the heart of the regions, the 15 regional savings banks are involved on a daily basis in their clients' projects and provide them with tailor-made solutions.Ithas now had 4.8 million members and 20.6 million customers, managed by 4,182 bank branches and the My Online Banker branch.It was created in 1818 and is headquartered in Paris, France.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Debt Financing, Seed
  • Geography: France

Investor stats

  • Total investments: 51
  • Round size: Seed $400k–$4.4M; Debt Financing $439k–$169M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Calicéo — Calicéo operates as a family group of aquatic fitness and beauty-massage spaces.
  • Leanspace — Today, space organizations need to build and manage increasingly complex ground software infrastructures: to design, integrate and operate their assets. To do so, they can rely on off-the-shelf systems (COTS) but lose control over their tools, or build everything from scratch which is slow and consumes lots of resources.Leanspace brings a new wayto build space software. We provide all the generic functions, easily consumable as-a-service, via APIs. The platform enables organizations to build all their systems in-house, but only developing the functionalities they need. This drastically reduces time & costs, keeps them in control, and boosts competitiveness.Leanspace-powered systems are integrated, collaborative and digital. Don’t reinvent the wheel, transform your business!
  • Miura Simulation — Miura helps engineers take control of their data, connect tools, reduce vendor friction, and lay the foundation for scalable AI.
Show all investments...

M Capital Partners
VC Fund · Toulouse, Midi-Pyrenees, France · 6 investments in France Biotech startups

M Capital is an independent investment company with +€500m AuM. A unique hub where entrepreneurs can have an equity finance and quasi-equity as well as a permanent support to accelerate their growth. In 2020, M Capital has funded over 200 French companies.

Show more...

Investment focus

  • Industry: Health Care, Software, Food and Beverage
  • Stage:Seed, Series A
  • Geography: France, United States, Canada

Investor stats

  • Total investments: 110
  • Round size: Seed $1.1M–$5.2M; Series A $3.3M–$7.7M
  • Lead/follow: 57% lead, 43% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Haiku — Haiku is revolutionizing legal practice by placing artificial intelligence and data at the service of law.
The company's objective is to free lawyers from tedious research and writing tasks to assist them in all of their work and thus increase their productivity while preserving their expertise.
  • MilkStraw AI — Saving companies up to 75% on AWS
  • The Sanctuary Group — The Sanctuary Group provides aqua-cycling, indoor cycling, boxing bootcamp, yoga, dance cardio, HIIT workouts, and kids’ swim classes.
Show all investments...

XAnge
VC Fund · Paris, Ile-de-France, France · 6 investments in France Biotech startups

XAnge is a Franco-German team of venture capital investors that manages €450 million and invests in digital, deeptech, and impact startups.It is the innovation brand of the Siparex group, a major player in French private equity. XAnge is a key European investor in early-stage startups and is looking for game-changing startups and entrepreneurswho rock the code[s].The Paris, Ile-de-France-located company was founded in 2004.

Show more...

Investment focus

  • Industry: Software, SaaS, E-Commerce
  • Stage:Series A, Seed, Series B
  • Geography: France, Germany, Belgium

Investor stats

  • Total investments: 218
  • Round size: Seed $1.1M–$7.6M; Series A $3M–$20M; Series B $6.6M–$68M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — raised $234M in 2021

Portfolio highlights

  • Dogami — Dogami is a mass-market NFT play-to-earn game that is centered around 3D NFT dog avatars.
  • Tomorro — Leeway helps you reduce the time spent on contract management and gives you more control and visibility over legal and financial risks.
  • Goodays (ex Critizr) — Critizr Connection is a Customer Interaction Management Platform that helps brands become customer-obsessed and deliver memorable customer experiences.
Show all investments...

Paca Investissement
VC Fund · Paris, Ile-de-France, France · 6 investments in France Biotech startups

Paca Investissement is specializes in investing in startups and developmental stages. The fund invests in the Provence-Alpes-Côte d'Azur (PACA) region.

Show more...

Investment focus

  • Industry: Software, Internet, Manufacturing
  • Stage:Seed, Series A
  • Geography: France

Investor stats

  • Total investments: 73
  • Round size: Seed $329k–$1.6M; Series A $411k–$9.2M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • GANGZ — Gangz is the first digital platform for talent recruitment: Models, hosts, extras and actors.
  • SailEazy — The SailEazy community offers all sailing enthusiasts the choice of freedom. A shared professional fleet, bases between the Atlantic and the Mediterranean ... discover a disruptive and innovative way of navigation. Throughout the year, 7 days / 7 and 24 hours a day, you can book and discover the high-performance sailboats of a professionalfleet, entirely managed by SailEazy. Subscriber, or punctual browser, autonomous or not, you have the choice. You freely determine your niche of reservation, without constraint time or duration, you choose your base of departure and your sailboat, according to your program (short exit, cruise, regatta, coastal, wide ...). Hourly pricing includes a 360 ° service keychain beyond the cost of the lease, including insurance, fuel, cleaning and equipment. Compulsive veiled, expert or contemplative, all members of the community have their way of navigating.
  • C4Diagnostics — Dana69 adalah tempat penyedia link login game online yang bisa di mainkan dengan menggunakan smartphone android dan iphone dan bisa melakukan top up slot dana 10k atau slot deposit dana 10k selalu online 24 jam.
Show all investments...

SOSV
VC Fund · Princeton, New Jersey, United States · 6 investments in France Biotech startups, 75 in the past 12 months

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1482
  • Lead/follow: no public data

Portfolio highlights

  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Show all investments...

Normandie Participations
VC Fund · Colombelles, Basse-Normandie, France · 5 investments in France Biotech startups

Normandie Participations is a venture capital fund that co-invests in companies based in Normandy. It invests through equity and quasi-equity in small and medium-sized enterprises. The firm was founded in 2016 and is based in Colombelles, France.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: France

Investor stats

  • Total investments: 37
  • Round size: Seed $871k–$2.3M; Series A $1.6M–$11M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Edumiam
  • RMAN Sync — RMAN Sync is the collaborative SRM by AI and deep learning that develops synergies between purchasing, supply chain, and trade.
  • Good Motors agency — Good Motors agency offers self-service motorcycle rentals near train stations and airports in France's most beautiful regions.
Show all investments...

Eurazeo
VC Fund · Paris, Ile-de-France, France · 5 investments in France Biotech startups

Eurazeo is a private equity and venture capital firm that invests in SMEs and manages a diversified portfolio of assets.With its expertise in private equity, real estate, and private debt, the group supports companies of all sizes in their development commitment through the commitment of its 235 professionals. It provides companies with thenecessary investments needed to realize their growth potential.The firm was founded in 1969 and is based in Paris, Ile-de-France, France.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Series B, Seed
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 298
  • Round size: Seed $3.2M–$16M; Series B $17M–$125M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Kolleno — The Kolleno platform helps small, medium and enterprise level businesses in various industries to accelerate and track payments, whilst driving a better customer experience.Kolleno is a unified AR Management Platform that streamlines your credit control, getting you paid faster and more consistently. Kolleno connects with your business softwarein a single click and simplifies all your cash-collection processes. Our AI-based technology allows you to prioritise your workflow, automate manual chasing, sequence personalised payment reminders through multiple communication channels, and reconcile payments with ease. We rethink the process and prioritise customer satisfaction to ensure cash conversions.
  • Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.
  • Celcius Logistics Solutions — India's Largest 'ONLINE " cold chain network.Book reefer vehicles, Cold Storages or get booking for your vehicle and cold storages across India instantly with the best price
Show all investments...

Emertec
VC Fund · Grenoble, Rhone-Alpes, France · 5 investments in France Biotech startups

EMERTEC’s experienced investment team has developed proven track record and has been able to develop close ties with major industrial players, many of them also being investors in their funds.These close ties are extremely valuable as to understand medium and long-term requirements of major order placers and high-level commercial opportunities.This brings visibility and confidence for entrepreneurs as well as for its investors.Their objective is to create value by turning ground-breaking technological innovations into commercial and financial successful companies.

Show more...

Investment focus

  • Industry: Energy, Software, Electronics
  • Stage:Series A, Series B
  • Geography: France, Canada, United States

Investor stats

  • Total investments: 25
  • Round size: Series A $1.4M–$6.8M; Series B $5.8M–$15M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • Ynsect — We are the world leader in insect ingredient production for animals, people, and plants. Our goal? To make the way we eat more nutritious and sustainable.
  • eLichens — eLichens is a sensor tech company that takes sensor technology to the next level. Its mission is to empower people, companies, and government agencies to improve air quality, both indoor and outdoor.
  • Osmia — Osmia SAS provides crop pollination services to improve yield and quality of agricultural production. Osmia intervenes in the context of specific problems on entomophilous or anemophilic pollination. Methodological approach and experience enables the company to find relevant solutions. It offers pollination studies and services for pre-base, baseor multiplication seeds. It also offers simple and efficient pollination services for arboriculture and optimize the yields and the quality of the productions of fruit trees.Osmia SAS was founded on 2014 and is headquartered in France.
Show all investments...

Entrepreneurs First
VC Fund · London, England, United Kingdom · 5 investments in France Biotech startups

We turn exceptional individuals into funded founders. We back you first, then give you a bridge to Silicon Valley.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Pre-Seed, Seed, Series A
  • Geography: United Kingdom, United States, India

Investor stats

  • Total investments: 146
  • Round size: Seed $1.1M–$7.7M; Pre-Seed $100k–$3.4M; Series A $9.4M–$60M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • Peakflo — If your finance team spends hours on tasks like manual data entry, 2-way/3-way matching, data validation, document categorization, vendor reconciliation, and cash application, it's time to streamline the entire process with Peakflo AI!
  • Sourcepulse — Sourcepulse is the internal status page for software delivery, alerting teams before costly delays. We collect anonymous feedback from project members to identify exactly what to fix, just like how Sentry captures system details for production errors.
  • Flare — Get Flare is a company that operates in the software industry. It offers a personal security system that combines software and wearable technology. The company's products are designed to empower users to feel confident and in control. One of their notable products includes a stylish, tech-enabled safety bracelet designed by survivors ofassault. This bracelet features hidden technology for lowkey safety. Additionally, Get Flare provides solutions to increase margins, capture more sales, and reduce waste by enabling customers to buy for future dates.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Pureos Bioventures
VC Fund · Küsnacht, Zurich, Switzerland · 5 investments in France Biotech startups

Venture capital for companies developing innovative therapeutics.

Show more...

Investment focus

  • Industry: Biotechnology, Therapeutics, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, Switzerland, United States

Investor stats

  • Total investments: 34
  • Round size: Series A $15M–$123M; Series B $6.6M–$100M; Series C $22M–$125M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — raised $205M in 2020

Portfolio highlights

  • Adcytherix — Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
  • Tavo Biotherapeutics — Tavo Biotherapeutics is a biotech company that develops injection therapies for eye diseases.
  • PulseSight Therapeutics — PulseSight is an ophthalmology drug development company creating novel, non-viral gene therapies with minimally invasive delivery technology to address the unmet need for treatments against severe retinal diseases leading to blindness.
Show all investments...

Finovam Gestion
VC Fund · Villeneuve, Provence-Alpes-Cote d'Azur, France · 5 investments in France Biotech startups

Finovam Gestion is an investment company approved by the AMF which takes minority stakes in innovative SMEs with high growth potential.The company, which manages €50M, invests in companies that have developed innovative offers in the following target sectors: Information and Communication Technology, Health and Biotechnologies, Agro-resources andEcotechnologies.Finovam Gestion has built solid relationships with the ecosystem of entrepreneurship (Industrials, Poles of Competitiveness, Incubators, Accelerators, Universities, and Research Centers) in all the sectors that we target in order to be able to source and do emerge the best companies.Among our investors (LPs), we can count BPI France, manufacturers (ADEO, LESAFFRE, TEREOS), banks (BNP Paribas, Caisse d´Epargne, Crédit Agricole) and the Haut de France and Grand-Est regions.

Show more...

Investment focus

  • Industry: Software, Information Technology, Medical
  • Stage:Seed, Series A
  • Geography: France, United States

Investor stats

  • Total investments: 41
  • Round size: Seed $505k–$3.4M; Series A $549k–$12M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Pikkopay — Pikkopay provides a mobile payment solution that transforms customer smartphones into cash registers. Customers can scan items, pay, and go, eliminating the need for traditional checkout lines. The service aims to streamline the shopping experience and increase user retention rates. Pikkopay is designed to save time for both customers andretailers, offering a hassle-free shopping experience.
  • StemInov — StemInov is a biotechnology company that focuses on the development of stem cell therapies for inflammatory diseases. The company's primary focus is on critical care, specifically septic shock and Acute Respiratory Distress Syndrome (ARDS). StemInov's approach is based on robust preclinical data and widely accepted safety measures. Thecompany is developing an off-the-shelf and allogenic cell therapy. StemInov is also working on a drug-based therapy using mesenchymatous stem cells from Wharton's jelly (WJ-MSC).
  • Lattice Medical — Lattice Medical also provides solutions for improving tissue engineering and regenerative medicine using 3D-printed bio-resorbable scaffolds.
Show all investments...

Blast. Club
VC Fund · Paris, Ile-de-France, France · 5 investments in France Biotech startups

Blast.club is an early-stage startup that allows investing in an exclusive selection of startups.

Show more...

Investment focus

  • Industry: Biotechnology, Information Technology, Apps
  • Stage:Seed, Series A
  • Geography: France, Germany

Investor stats

  • Total investments: 43
  • Round size: Seed $2.7M–$12M; Series A $4.1M–$32M
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • Wheere — Wheere invented geolocation technology that works both indoors and outdoors, as opposed to GPS, which only works outdoors. Wheere is betting on the creation of a dedicated electronic chip (ASIC), the deployment of world capitals, and the launch of a satellite constellation.
  • U-Space — U-Space Nanosatellites specializes in the design and manufacturing of next-generation nanosatellites tailored for a variety of applications including commercial services, scientific missions, and defense projects. With a focus on innovation, U-Space offers turnkey solutions encompassing a range of nanosatellite sizes such as 3U, 6U, and 12Uconfigurations. The company is dedicated to transforming client needs into high-performance space systems, marking significant milestones in the space industry with projects like the launch of NESS. U-Space collaborates with partners for components supply, contributing to the development of the French space sector and aiming to lead in nanosatellite constellations by 2025.
  • Astral Systems — Our compact multi-state fusion reactors offer high particle flux and exceptional lifetime performance, unlocking a wide variety of critical medical, industrial, and research applications today.
Show all investments...

Kima Ventures
VC Fund · Paris, Ile-de-France, France · 5 investments in France Biotech startups

Kima Ventures promotes the growth of startups, supporting them in the fastest and most effective ways.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Pre-Seed, Series A
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 574
  • Round size: Seed $550k–$5.5M; Pre-Seed $587k–$4.2M; Series A $1.2M–$16M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Hoora
  • Macrodata Labs — Macrodata Labs is a technology company that provides data infrastructure for the artificial intelligence and robotics industries.
  • Explora Project — Explora Project is specializing in adventure travel and expeditions to the 4 corners of the planet and all environments.
Show all investments...

Galion.exe
VC Fund · Paris, Ile-de-France, France · 5 investments in France Biotech startups, 12 in the past 12 months

Galion.exe invests in seed rounds and provide tools like guides, benchmarks, database, and open-source documents.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Biotechnology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: France, The Netherlands, Germany

Investor stats

  • Total investments: 27
  • Round size: Seed $3.1M–$9.4M; Pre-Seed $1.1M–$9.4M; Series A $11M–$23M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • Lemrock
  • Generare — Generare decodes microbial genomes to generate novel, high-quality molecular data for drug discovery. 200+ new molecules characterized and growing.
  • EGIDE — EGIDE develops advanced systems designed for rapid, cost-efficient drone interception. enables reliable neutralization of aerial threats across critical infrastructure and defense environments. Our technology delivers missile-grade effectiveness at a fraction of the cost, addressing the evolving challenges of modern airspace security.
Show all investments...

IXO Private Equity
VC Fund · Toulouse, Midi-Pyrenees, France · 5 investments in France Biotech startups

The private equity fund focused on adding high value.IXO Private Equity is a private equity management company recognized, approved and authorized by the Financial Market Authorities (AMF) operating under the number GP03018.IXO Private Equity is the most important independent regional private equity General Partner in France.The companymanages French General Private Equity Investment Funds (known in France as F.C.P.R.), Local Private Equity Investment Fund (known in France as F.I.P.), and Private Equity Investment Funds for Innovation (F.C.P.I.) to meet the equity needs for the best companies in Western and Southern France.

Show more...

Investment focus

  • Industry: Health Care, Manufacturing, Biotechnology
  • Stage:Private Equity, Series A
  • Geography: France, United States, Canada

Investor stats

  • Total investments: 64
  • Lead/follow: no public data

Portfolio highlights

  • Indy — Indy offers end-to-end and advanced AI-powered accounting software. Indy is an accounting robot that aims to automate the accounting of freelancers and professionals. It is an accounting robot for the liberal professions. It automates the management of accounting, recovers bank entries to turn them into accounting lines, and sends tax returnsdirectly to an AGM.It was founded in 2016 as Georges by Côme Fouques, Pablo Larvor, Romain Koenig, and Adrien Plat to simplify independent accounting, which is certainly simple but repetitive and time-consuming.
  • Wecasa — Wecasa is a data-driven marketplace that revolutionizes care services by focusing on user experience for customers and professionalsWecasa's mission is to make care services simple and accessible for a better quality of life. Through its app, users can book in seconds a reliable Professional for care services at home: wellness (haircut,beauty, massage), cleaning, and childcare. Available in Paris, top cities in France, London, and more European cities to come. Wecasa is proud to help 100.000+ customers and increase the business of 3000 independent professionals.
  • Farmitoo — Farmitoo is an online purchase of farm equipment directly from manufacturers.
Show all investments...

Andera Partners
VC Fund · Paris, Ile-de-France, France · 5 investments in France Biotech startups

Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Private Equity
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 180
  • Round size: Series B $14M–$85M; Private Equity $110M–$247M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $466M in 2022

Portfolio highlights

  • Senstronic — Senstronic designs and manufactures industrial sensing solutions focused on performance, reliability and technical expertise for demanding applications.
  • Inventiva Pharma — Inventiva Pharma is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical needs in the areas of fibrosis, lysosomal storage disorders and oncology.They have built a pipeline backed by a discovery engine with an extensive library ofproprietary molecules, a wholly-owned research and development facility and a team with significant expertise and deep experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging these assets and expertise, they are advancing two clinical candidates in three indications, as well as a deep pipeline of earlier stage programs.
  • Rivermark Medical — Rivermark Medical develops a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that restores urinary function. Developed by urologists to reliably reduce BPH symptoms with minimal side effects.
Show all investments...

M Ventures
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 4 investments in France Biotech startups

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 156
  • Lead/follow: no public data

Portfolio highlights

  • Akili Interactive Labs — Akili Interactive is a prescription digital medicine company combining scientific and clinical rigor with the ingenuity of the tech industry to reinvent medicine.
  • NanoSyrinx — NanoSyrinx is an award-winning, discovery stage biotechnology company based in the UK. We are using synthetic biology approaches to develop protein nanosyringes as a completely novel modality for intracellular delivery of protein and peptide biologic drugs.
  • Scipio Bioscience — Scipio Bioscience, a Paris-based biotechnology company, provides a novel sample preparation solutionfor single-cell studies, in the form of benchtop kits, for use in sequencing applications in clinical and basic research, in particular transcriptomics.
Show all investments...

HealthCap
VC Fund · Stockholm, Stockholms Lan, Sweden · 4 investments in France Biotech startups

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A
  • Geography: United States, Sweden, France

Investor stats

  • Total investments: 130
  • Round size: Series A $5.7M–$85M; Series B $12M–$92M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — raised $209M in 2019

Portfolio highlights

  • ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
  • Neobiomics — Neobiomics is a Swedish life-science company that develops nutritional products for preterm infants and neonatal care. Its best-known products include ProPrems® and NeoMega36®.
  • Ultragenyx Pharmaceutical — Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
Show all investments...

BNP Paribas Développement
VC Fund · Paris, Ile-de-France, France · 4 investments in France Biotech startups

BNP Paribas Développement is the investment arm of BNP Paribas that specializes in SME development. It specializes in second stage, mezzanine, bridge, acquisition, leveraged buyouts, management buyouts, recapitalization, special situations, and privatizations transactions.The firm considers investments in manufacturing, service industries,medicine, electronics, energy, chemistry, new materials, industrial automations, industrial goods and services, transportation, consumer goods, commerce and distribution, buildings and public works, wholesale retail, biotechnology, telecommunications, and information technology sectors.BNP Paribas Développement was established in 1988 and is based in Paris, France.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Series A, Seed
  • Geography: France, Germany, The Netherlands

Investor stats

  • Total investments: 139
  • Round size: Seed $2M–$10M; Series A $3.8M–$25M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • Primo1D — Discover Primo1D's smart RFID threads for sustainable textile traceability, boosting visibility, inventory accuracy & circularity across sectors.
  • Proteor — Proteor offers a complete range of high quality products and services to the O&P world, through more than 60 clinics.
  • DAMAE Medical — Damae Medical is a Paris, France-based medtech company. It has developed a medical device capable of seeing biological tissues in depth, at a cellular level and in vivo. This innovative optical imaging technology will especially allow dermatologists to evaluate in a precise, efficient and rapid way malignancy of tumors by a simple contact with thesurface of the skin. DAMAE Medical’s mission is to put the great power of bio-photonics at the service of opening new opportunities in medical imaging and diagnosis.
Show all investments...

Biotech VC funding in France at a glance

Stats across 1.1k deals from 999 investors.

999
investors
in France Biotech startups
1.1k
deals
in France Biotech startups
$5.7M
median round
in France Biotech startups
40%
lead investors
lead at least one round
17%
Seed
most common funding stage

Access all 999 VC funds in France Biotech startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech VC Funds in France investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 999 VC funds investing in France Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists